Intravesical Injection of Botulinum Toxin Type A in Men without Bladder Outlet Obstruction and Post-Deobstructive Prostate Surgery
Toxins · 2023
DOI: 10.3390/toxins15030221 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Toxins, 2023. Verfasst von Hsiang-Ying Lee und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung 80756, Taiwan. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Neuromuscular Agents, Transurethral Resection of Prostate, Urinary Bladder Neck Obstruction. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Buddhist Tzu Chi Medical Foundation grants.
Abstract (Originalsprache)
Purpose
A significant proportion of men without bladder outlet obstruction (BOO) have been reported to have overactive bladders (OAB). This article aimed to review the specific group of reports on the use of botulinum toxin type A (BTX-A) injections into the bladder wall. Materials and methods: Original articles reporting men with small prostates without BOO were identified through a literature search using the PubMed and EMBASE databases. Finally, we included 18 articles that reviewed the efficacy and adverse effects of BTX-A injections in men.
Results
Of the 18 articles screened, 13 demonstrated the therapeutic efficacy and adverse effects of BTX-A injections in men. Three studies compared BTX-A injection response between patients without prior prostate surgery and those undergoing prior prostate surgery, including transurethral resection of the prostate and radical prostatectomy (RP). Patients with prior RP experienced better efficacy and had a low risk of side effects. Two studies focused on patients who had undergone prior surgery for stress urinary incontinence, including male sling and artificial urethral sphincter surgery. The BTX-A injection was a safe and effective procedure for this specific group. OAB in men was found to have a different pathophysiology mechanism from that in female patients, which may decrease the efficacy of BTX-A injection in men. However, patients with small prostates and low prostate-specific antigen levels demonstrated better efficacy and tolerability after BTX-A injection.
Conclusions
Although intravesical injection of BTX-A was a good option for controlling refractory OAB in men, the evidence-based guidelines are still limited. Further research is necessary to better understand the role of BTX-A injections on various aspects and histories. Therefore, treating patients using strategies tailored to their individual conditions is important.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung 80756, Taiwan.
- Department of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80756, Taiwan.
- Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80756, Taiwan.
- Center for Cancer Research, Kaohsiung Medical University, Kaohsiung 80756, Taiwan.
- Department of Urology, School of Medicine, Tzu Chi University, Hualien 970473, Taiwan.
- Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970473, Taiwan.
ORCID-Profile: Hsiang-Ying Lee, Hann-Chorng Kuo
Förderung
- Buddhist Tzu Chi Medical Foundation grants
Zitieren
APA
Lee, H. Y., & Kuo, H. C. (2023). Intravesical Injection of Botulinum Toxin Type A in Men without Bladder Outlet Obstruction and Post-Deobstructive Prostate Surgery. Toxins. https://doi.org/10.3390/toxins15030221
Vancouver
Lee HY, Kuo HC. Intravesical Injection of Botulinum Toxin Type A in Men without Bladder Outlet Obstruction and Post-Deobstructive Prostate Surgery. Toxins. 2023. doi:10.3390/toxins15030221
BibTeX
@article{Lee2023,
author = {Lee, Hsiang-Ying and Kuo, Hann-Chorng},
title = {Intravesical Injection of Botulinum Toxin Type A in Men without Bladder Outlet Obstruction and Post-Deobstructive Prostate Surgery},
journal = {Toxins},
year = {2023},
doi = {10.3390/toxins15030221}
}
EUVIMED